CI

At a glance

ClinicalIndex Comparison Record
Phase 3Active· 1,455 enrolled / 1,455 target
Drug / intervention
PREVENTbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07217145
NCT07217145Phase 3ActiveHigh Momentum (164.6/mo)

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Randomized Controlled Trial (RCT)

University of Utah·interventional·Posted Oct 15, 2025·Updated Jun 5, 2026

In Brief

A Phase 3 clinical trial evaluating PREVENT for HPV Vaccination and 2 related conditions. Active but no longer recruiting, targeting 1,455 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States. The proposed study will assess the effectiveness of a clinic-based behavioral outreach intervention to increase HPV vaccination rates at community clinics in rural counties. The intervention consists of communication and engagement strategies delivered within routine care settings and is designed to pose no more than minimal risk to participants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3Active
20262027
First PostedOct 15, 2025
Enrollment StartOct 6, 2025
Primary CompletionJul 1, 2026
Study CompletionFeb 1, 2027
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9 months ago

Arms & Interventions

Automated Intervention (Auto)experimental

Auto intervention participants will be eligible for outreach delivered using automated phone calls, text, or email messages with the mode, frequency, timing of reminders, and message content. Automated outreach may also include innovative communication strategies, such as text-linked videos, P/C, or patient narratives. Auto outreach to P/C will invite P/Cs to attend free HPV vaccination visits and emphasize family-friendly hours.

Behavioral: PREVENT
Automated Intervention Plus (Auto-Plus)experimental

Auto-Plus intervention participants will be eligible for automated reminders, plus additional P/C prompts for patients who do not undergo vaccination within three weeks. These prompts may be delivered via live phone call outreach or patient navigation. Working with clinic leadership and previous research, activities will be selected from a list of possible options from the National HPV Vaccination Roundtable (previously chaired by Dr. Brewer) and our ranking of the effectiveness of language- and culturally- tailored intervention materials.

Behavioral: PREVENT
Usual Care (UC)no_intervention

The UC group will not receive tailored reminders but will only receive opportunistic vaccine reminders that are delivered during clinic visits or MyChart EHR-based patient portal reminders.

Interventions

PREVENTbehavioral

The proposed study will assess the effectiveness of clinic-based outreach to increase vaccination rates for HPV at community clinics in rural counties.